Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Gastroesophageal Reflux 2Barrett Esophagus 2Zollinger-Ellison Syndrome 1Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 2Omeprazole 2Lansoprazole 2Esomeprazole 2Capecitabine 2veliparib 1pazopanib 1cixutumumab 1YF 476 1Streptozocin 1Salts 1Pantoprazole 1Octreotide 1Interferons 1Fluorouracil 1Everolimus 1Doxorubicin 1Dexlansoprazole 1Clopidogrel 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Zollinger-Ellison Syndrome × YF 476 × Clear all
NCT02454075 2021-01-29

YF476 and Type II Gastric Carcinoids

Trio Medicines Ltd.

Phase 2 Terminated
3 enrolled 11 charts

Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡